Trial Profile
Safety and efficacy of deferasirox in patients with hematological malignancies: A real world German non-interventional study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2019
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Iron overload
- Focus Adverse reactions; Therapeutic Use
- Acronyms Exsept
- 13 Sep 2016 New trial record